Latest Shareholder Value News

Firetail Resources has sold its lithium rights over key Western Australian projects to Spartan Resources for $275,000, marking a strategic shift to focus on its flagship Skyline Copper Project in Canada.

Catalina Resources has made significant strides in its mineral exploration portfolio, acquiring over 650 km² in the Central Yilgarn and reporting promising high-grade gold and rare earth element intersections across multiple projects.

NuEnergy has finalized the Gas Sales and Purchase Agreement for its Tanjung Enim project and is advancing drilling preparations, marking a key step toward production and revenue generation.

Vinyl Group Ltd has updated the timeline for its Entitlements Offer, delaying the final allotment of underwritten shortfall securities to January 28, 2025, with shares to be listed the following day.

Cokal’s joint venture partner PT Petrindo has secured significant financing to develop its metallurgical coal mine and shared infrastructure, promising enhanced transport capacity and cost efficiencies for Cokal’s BBM project.

Ardiden Limited reports a robust cash balance of A$11.76 million and highlights strategic exploration focus on its Pickle Lake Gold Project, targeting promising gold and copper opportunities in Ontario.

Olympio Metals has secured an option to acquire 80% of the promising Dufay Copper-Gold Project in Quebec and plans to commence drilling imminently, while divesting non-core assets to strengthen its balance sheet.

Anax Metals has applied for a significant new exploration license in Western Australia's Pilbara region, broadening its footprint near De Grey Mining's Toweranna gold deposit and enhancing its prospects in gold and base metals.

Compumedics has locked in a pivotal five-year contract with Philips Australia, cementing Somfit as the leading device for pharmacy-based sleep testing and underpinning significant SaaS revenue growth through 2028.

Amcor plc has entered a definitive agreement to acquire Berry Global Group in a $9.9 billion all-stock transaction, aiming to create a global packaging leader. The merger, pending shareholder and regulatory approvals, is expected to close mid-2025.

Invex Therapeutics reports encouraging results from its collaboration with Tessara Therapeutics, showing Exenatide’s potential to improve neuronal survival in a 3D human brain model of Alzheimer's disease. The company maintains a stable cash position while exploring new neurological partnerships.

Evolution Mining delivered a standout December quarter with record cash flows, improved safety, and regulatory approval extending Cowal’s mine life to 2042. The company’s growth projects, including the Mungari mill expansion, are progressing ahead of schedule and under budget, positioning Evolution strongly for FY25.